Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
Actual shortage: | 212 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
To be discontinued: | 2 (1%) | |
Discontinued: | 297 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
86 (40%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-07-16 | 2020-07-23 | 120500 |
TEVA-FUROSEMIDE | 80MG | TABLET | Resolved | 2020-07-23 | 2021-01-28 | 120908 |
TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2020-07-23 | 2021-01-28 | 120914 |
TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-08-20 | 2020-12-17 | 122685 |
TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118915 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2020-07-30 | 2020-09-17 | 121506 |
TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2020-09-03 | 2020-10-01 | 123729 |
TEVA-GABAPENTIN | 400MG | CAPSULE | Resolved | 2020-10-01 | 2020-10-30 | 125494 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2020-10-22 | 2020-11-19 | 126921 |
TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2020-11-06 | 2020-11-12 | 128007 |
TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2020-11-06 | 2020-11-12 | 128037 |
TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2020-11-27 | 2021-02-11 | 129045 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-03-17 | 2017-04-25 | 3124 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-05-23 | 2017-09-19 | 10889 |
TEVA-GABAPENTIN | 800MG | TABLET | Resolved | 2020-04-02 | 2020-05-01 | 110694 |
TEVA-GABAPENTIN | 800MG | TABLET | Resolved | 2021-07-22 | 2021-09-02 | 142905 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2021-07-29 | 2021-11-05 | 143262 |
TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2021-08-13 | 2021-10-07 | 144111 |
TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2021-09-23 | 2021-10-07 | 146118 |
TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2022-01-27 | 2022-02-05 | 153715 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256146 |
TEVA-VALSARTAN | 80MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256149 |
TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256152 |
TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256155 |
TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |